bioAffinity Technologies (BIAF) Capital Expenditures (2023 - 2026)
bioAffinity Technologies (BIAF) reported Capital Expenditures of $5663.0 for Q1 2026, down 88.85% year-over-year from $50786.0 in Q1 2025, and up 566200.0% quarter-over-quarter from $1.0 in Q4 2025.
bioAffinity Technologies (BIAF) Capital Expenditures (2023 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 4 years of Capital Expenditures data on file, last reported at $5663.0 in Q1 2026.
- Capital Expenditures for Q1 2026 came in at $5663.0, down 88.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $15445.0 (down 82.54% YoY), and the FY2025 annual result was $60568.0, down 23.41% from the prior year.
- Capital Expenditures improved to $5663.0 in Q1 2026 per BIAF's latest filing, from $1.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $50786.0 in Q1 2025 and troughed at -$13442.0 in Q4 2023.
- A 4-year average of $12939.7 and a median of $5663.0 in 2026 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2024 and 2025: Capital Expenditures surged 5468.05% in 2024, then slumped 138.75% in 2025.
- A 4-year view of Capital Expenditures shows it stood at -$13442.0 in 2023, then jumped by 100.01% to $1.0 in 2024, then changed by 0.0% to $1.0 in 2025, then surged by 566200.0% to $5663.0 in 2026.
- Business Quant data shows BIAF's Capital Expenditures at $5663.0 in Q1 2026, $1.0 in Q4 2025, and -$3646.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 39.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 376.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 237.00 Mn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 8.27 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 76.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 22.14 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 127.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 38.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 17.41 Mn |
| 10 | bioAffinity Technologies | 2.08 Mn | -1.02 Mn | - | 5,663.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,663.00 |
| Mar 31, 2026 | 5,663.00 |
| Dec 31, 2025 | 1.00 |
| Dec 31, 2025 | 1.00 |
| Sep 30, 2025 | -3,646.00 |
| Sep 30, 2025 | -3,646.00 |
| Jun 30, 2025 | 13,427.00 |
| Jun 30, 2025 | 13,427.00 |
| Mar 31, 2025 | 50,786.00 |
| Mar 31, 2025 | 50,786.00 |
| Dec 31, 2024 | 1.00 |
| Dec 31, 2024 | 1.00 |
| Sep 30, 2024 | 9,410.00 |
| Sep 30, 2024 | 9,410.00 |
| Jun 30, 2024 | 28,285.00 |
| Jun 30, 2024 | 28,285.00 |
| Mar 31, 2024 | 41,387.00 |
| Mar 31, 2024 | 41,387.00 |
| Dec 31, 2023 | -13,442.00 |
| Dec 31, 2023 | -13,442.00 |